Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy

BACKGROUND: Alpha lipoic acid (ALA), a type of antioxidant, is used in combination with epalrestat in the treatment of diabetic peripheral neuropathy (DPN). However, whether combined treatment is superior to epalrestat monotherapy is controversial. METHODS: We conducted a systematic search of PubMed...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaotong, Lin, Haixiong, Xu, Shuai, Jin, Yuanlin, Zhang, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135078/
https://www.ncbi.nlm.nih.gov/pubmed/30233145
http://dx.doi.org/10.2147/DDDT.S168878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135078/
https://www.ncbi.nlm.nih.gov/pubmed/30233145
http://dx.doi.org/10.2147/DDDT.S168878

Ejemplares similares